UNIVERSAL HEALTH SERVICES INC UHS Cash Flow

Universal health services inc (UHS)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash Flows from Operating Activities:
Net income
144,460	248,010	100,870	241,265	237,398	163,622	174,881	230,711	228,669	225,035	145,362	190,388	210,527	178,738	157,265	195,449	215,719	191,317	163,654	201,404	194,323	190,492	96,038	166,614	151,852	133,186	123,099	167,803	129,935	147,660	81,373	117,444	142,570	108,007	94,842	116,034	129,987	50,816	65,802	76,415	82,762
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation & amortization
124,394	127,656	121,528	121,168	120,040	118,074	112,286	109,582	113,134	113,756	110,217	113,112	110,798	107,436	103,712	101,411	104,049	102,921	99,442	97,257	98,998	98,118	93,456	90,691	93,359	88,708	86,971	81,754	79,923	81,049	78,938	74,883	73,820	75,653	75,259	73,423	71,526	60,931	55,530	54,025	53,511
Stock-based compensation expense
18,000	17,200	17,500	17,100	17,600	16,000	15,900	15,000	19,700	13,862	13,785	13,705	15,348	11,751	11,665	11,489	13,204	9,826	9,671	9,645	10,829	8,379	7,768	7,793	7,152	7,711	6,493	6,468	7,111	6,329	5,193	5,510	5,486	4,791	4,769	4,711	3,954	4,121	4,351	4,262	4,065
Gain on sale of assets and businesses
-	-	-	-	-	0	0	1,810	703	0	0	0	0	-	-	-	-	-	-	-	-	0	-2,297	0	10,134	141	696	185	2,092	26,140	945	0	0	-	-	-	-	0	0	145	1,848
Changes in assets & liabilities, net of effects from acquisitions and dispositions:
Accounts receivable
-69,763	4,724	-63,997	-290	101,619	-31,890	10,074	-8,471	72,526	34,809	-9,149	-6,303	5,362	81,045	-38,893	-34,233	79,962	-15,063	-34,136	-1,959	96,972	7,515	36,328	-33,768	95,633	-49,553	17,037	365	81,859	-15,753	22,884	-82,733	146,670	31,138	26,039	-26,258	103,919	-29,477	-9,772	-29,976	46,499
Accrued interest
4,412	-3,171	3,910	-3,635	2,687	-1,330	6,007	-6,408	6,209	-6,452	5,958	-6,334	6,123	-6,463	5,855	-8,470	-688	396	-1,223	2,637	-1,117	2,147	-6,818	11,334	-11,063	11,573	2,823	-1,702	-11,497	11,749	3,972	-2,593	-13,280	16,720	-15,452	15,184	-12,875	29	-10,194	10,114	-8,357
Accrued and deferred income taxes
-45,200	-28,520	36,868	69,137	-52,291	887	10,625	104,214	-61,674	-13,772	14,648	107,798	-102,269	-9,881	5,810	73,134	-91,131	21,826	23,438	68,180	-79,050	-52,312	8,957	74,756	-65,321	-29,752	-1,829	56,344	-59,624	5,406	4,215	71,516	-75,471	24,725	-47,529	-124,414	68,994	2,524	-6,602	-33,434	37,380
Other working capital accounts
-73,929	50,598	-60,180	77,796	-107,878	64,461	-80,180	50,055	-59,032	38,894	-117,444	160,592	-66,877	50,498	-1,672	-24,343	-98,972	71,538	43,119	-18,930	29,829	-14,299	-41,874	-52,738	34,999	-15,921	22,108	-72,206	39,785	-71,470	29,831	-34,989	48,074	-45,960	25,925	21,361	27,056	53,134	-42,450	13,364	2,389
Other assets and deferred charges
-11,084	42,442	-16,570	-2,438	3,771	-5,704	22,989	8,706	5,438	6,590	1,623	12,069	7,654	14,071	3,302	2,346	5,803	-2	-2,555	-4,308	234	2,201	-5,453	-433	-9,982	4,441	-4,356	-2,407	-6,662	-5,017	-12,093	-6,746	-7,120	-16,945	-8,690	-4,748	-6,777	-14,065	4,010	-1,973	489
Other
-3,038	64,168	-6,778	-52,292	2,605	1,544	342	-11,633	8,211	76,433	-31,253	-23,182	-229	23,099	5,990	31,139	20,911	10,155	10,977	-15,644	17,807	9,449	-2,908	-259	-3,833	17,693	1,709	2,479	1,604	534	3,783	4,132	-2,082	-5,533	678	-7,740	11,208	5,368	-43	-349	-4,164
Excess income tax benefits related to stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	8,812	1,160	24,245	11,002	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued insurance expense, net of commercial premiums paid
49,559	29,427	24,426	27,421	24,398	23,477	23,131	23,130	23,125	21,781	21,911	36,896	22,007	18,589	21,818	21,615	22,616	15,180	25,204	27,763	22,748	1,547	19,209	17,218	21,302	-2,415	21,184	-45,552	22,962	-4,092	24,511	17,660	24,581	12,426	23,706	23,736	23,744	-13,031	17,279	-3,469	18,960
Payments made in settlement of self-insurance claims
26,924	29,735	23,931	21,795	22,320	22,924	14,617	19,841	18,765	21,968	19,465	12,410	25,349	21,825	27,125	15,714	17,298	23,727	14,372	14,477	26,562	16,411	13,312	19,129	20,793	15,636	17,971	19,953	17,085	16,200	11,070	29,535	18,279	36,869	12,399	18,452	14,913	12,843	9,632	17,511	10,187
Net cash provided by operating activities
502,062	389,159	425,224	192,282	431,804	325,342	342,437	197,059	409,904	368,868	344,921	50,687	483,109	197,330	300,083	361,200	475,229	271,763	264,896	260,328	271,275	346,322	231,138	263,777	194,639	308,318	185,006	212,420	178,497	264,225	162,144	245,639	127,223	148,181	206,726	172,599	183,177	88,529	185,091	88,265	139,459
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals
184,102	153,848	156,327	154,072	169,848	143,613	151,097	181,211	189,041	138,813	156,241	118,114	144,338	123,776	148,448	120,501	127,214	109,743	98,998	81,304	89,276	81,789	122,575	94,399	92,387	78,742	103,807	80,025	95,919	81,001	99,840	89,788	92,563	90,278	79,164	59,682	56,558	61,524	56,110	59,064	62,576
Acquisition of property and businesses
-	-	-	-	-	2,448	87,085	0	20,931	3,268	0	1,778	17,832	477,582	108,696	7,982	19,543	350,552	148,603	0	34,500	28,981	331,405	67,699	3,301	11,316	0	1,320	0	-	-	-	-	-	-	-	-	-	-	-	-
Inflows (outflows) from foreign exchange contracts that hedge our net U.K. investment
-51,691	110,049	-36,923	-81,371	28,008	-40,063	-3,790	-68,151	45,853	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds received from sales of assets and businesses
-	-	-	-	-	0	0	12,663	839	108	0	0	0	-	-	-	-	-	-	-	-	0	3,728	0	11,450	364	3,110	27,351	6,657	93,117	2,733	0	53,461	43,910	21,641	1,050	991	0	16,460	2,106	2,894
Costs incurred for purchase and implementation of information technology applications
1,857	3,178	4,347	4,215	9,678	10,756	1,400	15,517	8,570	2,646	6,953	9,992	9,456	21,475	0	0	0	-	-	-	-	2,284	2,805	1,895	6,504	7,458	8,957	16,984	16,412	12,508	13,846	13,507	14,501	10,375	16,458	19,561	-8,145	31,187	-4,862	-4,612	-3,742
Decrease (Increase) in capital reserves of commercial insurance subsidiary
-	-	-	-	-	0	0	0	-100	100	0	0	3,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment in, and advances to, joint ventures and other
751	2,630	0	11,070	879	1,421	-149	5,384	8,675	7,976	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Return of Deposit on terminated purchase agreement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-6,500	0	0	0	0	-	-	-	-
Net cash used in investing activities
-135,019	-275,757	-116,254	-87,986	-208,413	-118,175	-235,643	-121,298	-272,131	-217,028	-163,194	-129,884	-174,626	-622,833	-257,144	-128,483	-146,757	-462,948	-244,857	-81,304	-123,776	-125,054	-453,057	-163,993	-90,742	-97,152	-109,654	-70,978	-105,674	-503,147	-124,569	-114,771	-47,103	-77,610	-82,580	-61,903	-63,712	-1,767,605	-301,484	-61,570	-63,424
Cash Flows from Financing Activities:
Reduction of long-term debt
185,098	-11,033	39,558	-85,923	114,540	730,527	17,499	-58,206	140,676	-420	97,851	-214,958	260,633	-355,788	-28,380	676,680	166,671	-139,205	-48,287	96,787	158,871	36,586	663,417	70,072	109,054	205,993	38,135	126,170	69,926	-278,182	932,143	124,744	70,942	113,978	66,973	64,163	136,403	1,197,486	116,626	9,611	68,363
Additional borrowings
5,453	24,120	-162,100	168,500	8,700	708,847	51,900	10,000	20,500	-2,024	21,524	0	21,600	144,800	3,761	1,007,839	14,400	218,100	11,100	-15,600	20,800	-139,800	969,800	-11,900	11,900	14,261	-9,500	1,500	9,500	7,500	906,000	0	0	62,100	0	-37,500	73,500	3,016,146	250,000	0	0
Financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	119	1,596	10,690	44	515	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	49	25	394	23,140	96,799	5,016	0	0
Repurchase of common shares
172,092	182,528	93,327	350,864	143,785	136,169	126,472	125,343	9,441	121,531	95,407	118,296	29,167	56,203	58,038	68,097	171,042	79,920	61,705	39,390	28,767	37,457	27,519	21,780	13,993	5,015	813	7,346	14,027	9,478	6,749	910	2,017	15,950	38,369	2,993	3,170	7,565	260	1,546	2,157
Dividends paid
17,344	17,447	17,603	8,872	9,081	9,256	9,282	9,382	9,422	9,435	9,496	9,618	9,662	9,678	9,713	9,727	9,757	9,836	9,892	9,905	9,899	9,871	9,910	4,951	4,933	4,915	4,911	4,925	4,870	43,876	4,846	4,841	4,832	4,828	4,875	4,887	4,876	4,867	4,862	4,859	4,834
Issuance of common stock
3,002	2,558	2,977	2,545	2,726	2,459	2,778	2,414	2,545	2,617	2,710	2,387	2,540	3,124	2,017	2,031	2,331	2,411	1,991	2,271	1,768	1,956	1,620	1,842	1,445	1,612	1,361	1,503	1,232	1,607	1,253	1,559	1,016	1,183	1,188	1,157	1,251	-1,610	1,371	2,206	1,627
Excess income tax benefits related to stock based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	798	7,682	20,807	3,670	1,749	16,743	11,750	4,312	724	5,819	9,266	-	-	-	-	-	-	-	-	-	-	-	-
Profit distributions to noncontrolling interests
5,735	3,972	237	1,336	10,314	6,352	329	3,697	4,217	8,789	4,494	7,312	4,118	8,530	1,438	56,208	3,407	26,255	12,670	20,882	2,413	8,606	11,890	11,195	1,989	10,081	24,514	16,660	10,074	13,208	122	10,990	2,575	4,535	10,761	19,176	4,025	8,898	11,222	7,713	4,623
Proceeds received from sale/leaseback of real property
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	214	12,551	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-371,814	-164,790	-309,848	-104,104	-266,294	-184,011	-98,924	-68,556	-140,711	-138,784	-183,048	82,119	-279,440	429,182	-36,627	-229,532	-334,190	213,903	-22,091	-172,397	-144,024	-228,257	247,020	-101,313	-104,874	-206,050	-75,788	-146,279	-78,899	236,741	-44,864	-139,926	-79,350	-68,489	-119,815	-127,956	-96,863	1,698,921	113,685	-21,223	-78,350
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-1,673	2,218	-986	-1,067	794	-1,163	-604	-2,995	1,857	162	547	653	285	473	-841	-1,502	-920	-1,013	-889	759	-466	-653	-122	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in cash, cash equivalents and restricted cash
-6,444	-49,170	-1,864	-875	-42,109	21,993	7,266	4,210	-1,081	13,218	-774	3,575	29,328	4,152	5,471	1,683	-6,638	21,705	-2,941	7,386	3,009	-7,642	24,979	-1,529	-977	5,116	-436	-4,837	-6,076	-2,181	-7,289	-9,058	770	2,082	4,331	-17,260	22,602	19,845	-2,708	5,472	-2,315
Supplemental Disclosures of Cash Flow Information:
Interest paid
39,483	34,707	44,076	37,573	41,050	36,131	43,272	29,351	41,539	28,091	40,677	27,361	39,404	24,196	29,325	26,425	27,133	27,188	24,148	28,560	27,158	31,609	38,592	41,185	18,893	42,829	34,363	31,085	22,982	52,855	42,402	36,213	25,945	55,616	18,499	65,083	37,130	43,316	3,801	24,301	5,482
Income taxes paid, net of refunds
6,783	39,324	75,894	140,317	5,087	46,351	65,356	179,381	2,749	64,970	89,671	210,961	5,253	85,437	93,227	156,854	9,093	106,534	107,487	163,761	2,876	46,464	55,714	149,670	6,764	41,606	65,737	147,645	4,908	76,925	46,328	138,152	3,419	73,761	5,736	79,005	4,527	38,567	33,578	73,211	6,732
Noncash purchases of property and equipment
58,935	-20,038	11,629	-64	71,987	-11,258	-2,810	7,034	84,708	17,538	1,869	6,662	56,427	20,383	2,572	-4,627	47,374	11,858	2,740	1,406	33,082	10,143	-32,694	8,487	49,533	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right-of-use assets obtained in exchange for lease obligations
29,112	19,900	5,000	3,000	356,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-